A Tale of Two Viruses: Does Heterologous Flavivirus Immunity Enhance Zika Disease?

Carlos A. Sariol; Mauricio L. Nogueira; Nikos Vasilakis

doi:10.1016/j.tim.2017.10.004

A Tale of Two Viruses: Does Heterologous Flavivirus Immunity Enhance Zika Disease?

Carlos A. Sariol, Mauricio L. Nogueira, Nikos Vasilakis

Pathology

Research output: Contribution to journal › Review article › peer-review

26 Scopus citations

Abstract

The rise of Zika virus (ZIKV) and its unusual clinical manifestations provided ground for speculative debate. The clinical severity of secondary dengue virus (DENV) infections is associated with antibody-dependent enhancement (ADE), and it was recently suggested that previous exposure to DENV may worsen ZIKV clinical outcomes. In this Opinion article we analyze the relationship among different flaviviruses and ADE. We discuss new evidence obtained in non-human primates and human cohorts demonstrating that there is no correlation to ADE when ZIKV infection occurs in the presence of pre-existing DENV immunity. We propose a redefinition of ADE in the context of complex immunological flavivirus interactions to provide a more objective perspective when translating in vitro or in vivo observations into the clinical setting.

Original language	English (US)
Pages (from-to)	186-190
Number of pages	5
Journal	Trends in Microbiology
Volume	26
Issue number	3
DOIs	https://doi.org/10.1016/j.tim.2017.10.004
State	Published - Mar 2018

Keywords

ADE
Zika
dengue
flavivirus

ASJC Scopus subject areas

Microbiology
Microbiology (medical)
Virology
Infectious Diseases

Access to Document

10.1016/j.tim.2017.10.004

Cite this

@article{9c684783593848d6ba747fcb0f28e856,

title = "A Tale of Two Viruses: Does Heterologous Flavivirus Immunity Enhance Zika Disease?",

abstract = "The rise of Zika virus (ZIKV) and its unusual clinical manifestations provided ground for speculative debate. The clinical severity of secondary dengue virus (DENV) infections is associated with antibody-dependent enhancement (ADE), and it was recently suggested that previous exposure to DENV may worsen ZIKV clinical outcomes. In this Opinion article we analyze the relationship among different flaviviruses and ADE. We discuss new evidence obtained in non-human primates and human cohorts demonstrating that there is no correlation to ADE when ZIKV infection occurs in the presence of pre-existing DENV immunity. We propose a redefinition of ADE in the context of complex immunological flavivirus interactions to provide a more objective perspective when translating in vitro or in vivo observations into the clinical setting.",

keywords = "ADE, Zika, dengue, flavivirus",

author = "Sariol, {Carlos A.} and Nogueira, {Mauricio L.} and Nikos Vasilakis",

note = "Publisher Copyright: {\textcopyright} 2017 Elsevier Ltd",

year = "2018",

month = mar,

doi = "10.1016/j.tim.2017.10.004",

language = "English (US)",

volume = "26",

pages = "186--190",

journal = "Trends in Microbiology",

issn = "0966-842X",

publisher = "Elsevier Ltd",

number = "3",

}

TY - JOUR

T1 - A Tale of Two Viruses

T2 - Does Heterologous Flavivirus Immunity Enhance Zika Disease?

AU - Sariol, Carlos A.

AU - Nogueira, Mauricio L.

AU - Vasilakis, Nikos

PY - 2018/3

Y1 - 2018/3

N2 - The rise of Zika virus (ZIKV) and its unusual clinical manifestations provided ground for speculative debate. The clinical severity of secondary dengue virus (DENV) infections is associated with antibody-dependent enhancement (ADE), and it was recently suggested that previous exposure to DENV may worsen ZIKV clinical outcomes. In this Opinion article we analyze the relationship among different flaviviruses and ADE. We discuss new evidence obtained in non-human primates and human cohorts demonstrating that there is no correlation to ADE when ZIKV infection occurs in the presence of pre-existing DENV immunity. We propose a redefinition of ADE in the context of complex immunological flavivirus interactions to provide a more objective perspective when translating in vitro or in vivo observations into the clinical setting.

AB - The rise of Zika virus (ZIKV) and its unusual clinical manifestations provided ground for speculative debate. The clinical severity of secondary dengue virus (DENV) infections is associated with antibody-dependent enhancement (ADE), and it was recently suggested that previous exposure to DENV may worsen ZIKV clinical outcomes. In this Opinion article we analyze the relationship among different flaviviruses and ADE. We discuss new evidence obtained in non-human primates and human cohorts demonstrating that there is no correlation to ADE when ZIKV infection occurs in the presence of pre-existing DENV immunity. We propose a redefinition of ADE in the context of complex immunological flavivirus interactions to provide a more objective perspective when translating in vitro or in vivo observations into the clinical setting.

KW - ADE

KW - Zika

KW - dengue

KW - flavivirus

UR - http://www.scopus.com/inward/record.url?scp=85032954473&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032954473&partnerID=8YFLogxK

U2 - 10.1016/j.tim.2017.10.004

DO - 10.1016/j.tim.2017.10.004

M3 - Review article

C2 - 29122447

AN - SCOPUS:85032954473

SN - 0966-842X

VL - 26

SP - 186

EP - 190

JO - Trends in Microbiology

JF - Trends in Microbiology

IS - 3

ER -

A Tale of Two Viruses: Does Heterologous Flavivirus Immunity Enhance Zika Disease?

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this